These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1278313)

  • 21. Studies on the in vitro metabolism of compounds related to lysergic acid diethylamide (LSD).
    Niwaguchi T; Inoue T; Sakai T
    Biochem Pharmacol; 1974 Nov; 23(21):3063-6. PubMed ID: 4429602
    [No Abstract]   [Full Text] [Related]  

  • 22. Selective labeling of serotonin receptors by d-[3H]lysergic acid diethylamide in calf caudate.
    Whitaker PM; Seeman P
    Proc Natl Acad Sci U S A; 1978 Dec; 75(12):5783-7. PubMed ID: 32537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo 3H-d-LSD binding in small punched out rat brain regions.
    Kräuchi K; Feer H
    Experientia; 1980 Sep; 36(9):1094-5. PubMed ID: 7418848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of specific binding sites labeled by [3H]LSD in coronal sections of paraformaldehyde-fixed rat brain.
    Beck SG; Azmitia EC
    Brain Res; 1985 Oct; 345(2):369-73. PubMed ID: 4041897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereospecific binding of D-lysergic acid diethylamide (LSD) to brain membranes: relationship to serotonin receptors.
    Bennett JP; snyder SH
    Brain Res; 1975 Sep; 94(3):523-44. PubMed ID: 239784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in d-[3H]lysergic acid diethylamide binding in mouse cortex and hippocampus in vivo and in vitro revealed by radioautography and rapid filtration studies.
    Ebersole BJ; Weinstein H; Maayani S
    J Pharmacol Exp Ther; 1984 Jun; 229(3):865-71. PubMed ID: 6726661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and radioautography of [3H]LSD binding by rat brain slices in vitro: the effect of 5-hydroxytryptamine.
    Meibach RC; Maayani S; Green JP
    Eur J Pharmacol; 1980 Oct; 67(4):371-82. PubMed ID: 7449822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LSD: autoradiographic study on the placental transfer and tissue distribution in mice.
    Idänpään-Heikkilä JE; Schoolar JC
    Science; 1969 Jun; 164(3885):1295-7. PubMed ID: 5814183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of lysergic acid diethylamide (LSD) to 2-oxo-3-hydroxy LSD (O-H-LSD) in human liver microsomes and cryopreserved human hepatocytes.
    Klette KL; Anderson CJ; Poch GK; Nimrod AC; ElSohly MA
    J Anal Toxicol; 2000 Oct; 24(7):550-6. PubMed ID: 11043658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
    Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
    Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
    Peroutka SJ; Snyder SH
    Mol Pharmacol; 1979 Nov; 16(3):687-99. PubMed ID: 530254
    [No Abstract]   [Full Text] [Related]  

  • 32. Photoreactivity of lysergic acid diethylamide and its possible utility as a photoaffinity labeling reagent.
    Walker EB; McNall SJ; Mansour TE
    Biochem Pharmacol; 1983 Apr; 32(7):1251-7. PubMed ID: 6847715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A possible mechanism for decrease in serum thyroxine level by polychlorinated biphenyls in Wistar and Gunn rats.
    Kato Y; Ikushiro S; Haraguchi K; Yamazaki T; Ito Y; Suzuki H; Kimura R; Yamada S; Inoue T; Degawa M
    Toxicol Sci; 2004 Oct; 81(2):309-15. PubMed ID: 15254343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Species differences in disposition of benzo[a]pyrene.
    Weyand EH; Bevan DR
    Drug Metab Dispos; 1987; 15(4):442-8. PubMed ID: 2888614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysergic acid diethylamide: radioimmunoassay.
    Taunton-Rigby A; Sher SE; Kelley PR
    Science; 1973 Jul; 181(4095):165-6. PubMed ID: 4736456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Spectrophotometric determination of lysergic acid diethylamide in salts and animal blood].
    Nekrasov VI; Davydova ON
    Farmatsiia; 1970; 19(3):39-40. PubMed ID: 5429692
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatocyte cotransport of taurocholate and bilirubin glucuronides: role of microtubules.
    Crawford JM; Gollan JL
    Am J Physiol; 1988 Jul; 255(1 Pt 1):G121-31. PubMed ID: 3389412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of [3H]LSD with serotonin receptors in human brain.
    Cross AJ
    Eur J Pharmacol; 1982 Aug; 82(1-2):77-80. PubMed ID: 7128680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.
    Langer SZ; Moret C
    J Pharmacol Exp Ther; 1982 Jul; 222(1):220-6. PubMed ID: 6953233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: absence of a metabolic component.
    Winter JC
    J Pharmacol Exp Ther; 1971 Sep; 178(3):625-30. PubMed ID: 5571911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.